Age-related macular degeneration (AMD) is the leading cause of vision loss in adults over 50 in developed countries. This comprehensive guide explains what AMD is, how it's detected, and the latest evidence-based approaches for prevention and treatment.
Key Takeaways
- Leading Cause: AMD is the leading cause of vision loss in adults over 50 in developed countries
- Two Types: Dry AMD (85-90% of cases) progresses slowly; Wet AMD (10-15%) causes more severe vision loss
- Risk Factors: Age, genetics, smoking, diet, and cardiovascular health all influence AMD risk
- Evidence-Based Prevention: AREDS2 supplements, Mediterranean diet, not smoking, and UV protection
- Treatment Options: Anti-VEGF injections for wet AMD; supplements and monitoring for dry AMD
As our population ages, AMD is becoming increasingly prevalent. Understanding this condition is crucial for early detection and management. This article brings together the latest scientific evidence and clinical recommendations to provide a comprehensive overview of AMD in 2025.
What is Age-Related Macular Degeneration?
Age-related macular degeneration is a progressive eye condition that affects the macula, the central portion of the retina responsible for sharp, central vision. The macula allows us to see fine details clearly and is essential for activities like reading, driving, and recognizing faces.
Normal Vision
With normal vision, the macula functions properly, allowing for:
- Clear central vision
- Ability to see fine details
- Normal color perception
- Ability to recognize faces
- Ability to read and drive safely
Vision with AMD
As AMD progresses, vision becomes increasingly compromised:
- Blurred or distorted central vision
- Dark or empty areas in the center of vision
- Difficulty reading or recognizing faces
- Colors appearing less vibrant
- Straight lines appearing wavy or curved
As AMD progresses, it can lead to blurred or distorted central vision and eventually may cause a blind spot in the center of your visual field. While AMD doesn't typically cause complete blindness as peripheral vision usually remains intact, it can significantly impact quality of life and independence.
Types of AMD
There are two main types of AMD, each with distinct characteristics and progression patterns:
1. Dry AMD (Non-Neovascular)
Dry AMD accounts for approximately 85-90% of all cases. It's characterized by the presence of drusen (yellow deposits beneath the retina), thinning of the macula, and gradual loss of macular function.
Progression Stages:
Stage | Characteristics | Vision Impact | Management |
---|---|---|---|
Early | Medium-sized drusen | Usually no vision loss | Regular monitoring; healthy lifestyle |
Intermediate | Large drusen; pigment changes in retina | May experience mild vision loss | AREDS2 supplements; more frequent monitoring |
Advanced (Geographic Atrophy) | Breakdown of light-sensitive cells and supporting tissue | Blind spot in central vision | Low vision aids; clinical trials for emerging treatments |
Dry AMD typically progresses slowly over years or decades. While there is no FDA-approved treatment to reverse dry AMD yet, lifestyle modifications and nutritional supplements can help slow its progression.
2. Wet AMD (Neovascular)
Wet AMD accounts for approximately 10-15% of cases but is responsible for 90% of severe vision loss from AMD. It's characterized by abnormal blood vessel growth (neovascularization) beneath the retina, which can leak fluid and blood, damaging the macula.
Key Characteristics:
- Abnormal blood vessel growth beneath the retina
- Leakage of blood and fluid
- More rapid vision loss than dry AMD
- Can develop suddenly
- May cause severe distortion of straight lines (metamorphopsia)
Warning Signs:
- Sudden decrease in central vision
- Straight lines appearing wavy or distorted
- Dark spot in central vision
- Colors appearing less vibrant
- Size of objects may appear different between eyes
Wet AMD can develop suddenly and requires prompt treatment to preserve vision. With early detection and appropriate treatment, many people with wet AMD can maintain useful vision.
Critical Warning Signs of AMD
If you experience any of these symptoms, consult an eye care professional immediately:
- Sudden blurred or distorted central vision
- A blind spot or dark area in the center of your visual field
- Difficulty recognizing faces
- Requiring brighter light for reading
- Colors appearing less vibrant
- Most important: Straight lines appearing wavy (a key warning sign of wet AMD)
Note: Wet AMD is considered an ocular emergency. Early treatment is essential to preserve vision.
Risk Factors for AMD
Several factors can increase your risk of developing AMD. Understanding these risk factors can help you take appropriate preventive measures and make informed lifestyle choices.
Non-Modifiable Risk Factors
- Age: The risk increases significantly after age 50 and continues to rise with age. By age 75, approximately 30% of people have some form of AMD.
- Genetics: Family history of AMD increases risk; several genetic markers have been identified, including variants in the CFH and ARMS2 genes.
- Race: More common in Caucasians than in African Americans or Hispanics, possibly due to differences in melanin content in the retinal pigment epithelium.
- Eye color: More common in people with light-colored eyes, which contain less protective melanin.
- Gender: Slightly more common in females, particularly after age 75.
Modifiable Risk Factors
- Smoking: Doubles the risk of AMD and is the most significant modifiable risk factor. Current smokers have 2-3 times the risk of developing AMD compared to never-smokers.
- Cardiovascular disease: Heart disease, high blood pressure, high cholesterol, and obesity all increase AMD risk due to impaired blood flow to the choroid.
- Diet: Low intake of antioxidants, omega-3 fatty acids, and lutein/zeaxanthin from fruits, vegetables, and fish is associated with higher AMD risk.
- Sun exposure: Excessive exposure to UV and blue light may increase oxidative stress in the retina.
- Physical inactivity: Sedentary lifestyle is associated with higher AMD risk, independent of its effect on obesity and cardiovascular health.
Risk Assessment: Are You at High Risk for AMD?
You may be at high risk for AMD if you have multiple risk factors, particularly:
- Age over 60
- Family history of AMD
- Current smoker
- Caucasian race
- Light-colored eyes
- Cardiovascular disease or risk factors (high blood pressure, high cholesterol)
If you have multiple risk factors, talk to your eye care professional about:
- More frequent eye examinations
- Home monitoring with an Amsler grid
- Appropriate nutritional supplements
- Lifestyle modifications to reduce risk
Diagnosis of AMD
Early detection of AMD is crucial for effective management. Regular comprehensive eye examinations are recommended for everyone over age 50, and more frequently for those with risk factors.
Diagnostic Procedures
- Visual acuity test: Measures how well you see at various distances
- Dilated eye exam: Allows examination of the retina and macula
- Amsler grid: Helps detect distortions in central vision
- Tonometry: Measures intraocular pressure
- Optical Coherence Tomography (OCT): Provides detailed cross-sectional images of the retina
- OCT Angiography: Shows blood flow in retinal vessels without dye injection
- Fluorescein Angiography: Uses dye to highlight abnormal blood vessels
- Fundus Autofluorescence: Detects changes in retinal pigment epithelium
- Amsler Grid: Simple paper grid that helps detect changes in central vision
- Digital Monitoring: Apps and devices that track visual changes over time
- ForeseeHome: FDA-approved home monitoring device for patients with intermediate AMD
- MyVisionTrack: Mobile app for self-monitoring visual function
The Amsler Grid Test
The Amsler grid is a simple but effective tool for monitoring changes in your central vision at home:
- Hold the grid at normal reading distance (about 12-15 inches)
- Wear your reading glasses if you normally use them
- Cover one eye and focus on the central dot
- Note any areas where the lines appear wavy, blurry, or missing
- Repeat with the other eye
- Perform this test at least once a week

Report any new distortions or changes to your eye care professional immediately, as this could indicate progression to wet AMD.
Prevention and Risk Reduction
While AMD cannot always be prevented, several evidence-based strategies can reduce your risk or slow progression if you already have early AMD.
Evidence-Based Prevention Strategies
AREDS2 Formula Supplements
The Age-Related Eye Disease Study 2 (AREDS2) established that a specific formulation of vitamins and minerals can reduce the risk of progression to advanced AMD by about 25% in people with intermediate AMD or advanced AMD in one eye.
AREDS2 Formula
- 500 mg vitamin C
- 400 IU vitamin E
- 10 mg lutein
- 2 mg zeaxanthin
- 80 mg zinc
- 2 mg copper
Diet and Antioxidants
A diet rich in antioxidants, particularly from fruits and vegetables, is associated with lower AMD risk:
- Leafy greens: Spinach, kale, and collard greens are rich in lutein and zeaxanthin
- Colorful fruits and vegetables: Orange, yellow, and red produce (bell peppers, carrots, sweet potatoes)
- Omega-3 fatty acids: Found in fatty fish like salmon, mackerel, and sardines
- Low-glycemic diet: Reducing intake of refined carbohydrates may lower AMD risk
Smoking Cessation
Smoking is the most significant modifiable risk factor for AMD. Studies show that smokers have 2-3 times the risk of developing AMD compared to never-smokers. The risk begins to decrease after quitting but may take up to 20 years to return to the level of never-smokers.
If you smoke, quitting is the single most important step you can take to reduce your AMD risk.
Other Important Modifications
- UV and Blue Light Protection: Wear sunglasses that block 99-100% of UVA and UVB radiation when outdoors. Consider blue light filtering glasses when using digital devices for extended periods.
- Cardiovascular Health: Manage blood pressure, cholesterol, and weight through diet, exercise, and medication if prescribed.
- Physical Activity: Regular exercise improves circulation and may help reduce AMD risk independently of its effects on other risk factors.
- Mediterranean Diet: Following a Mediterranean diet pattern (rich in fruits, vegetables, whole grains, fish, and olive oil) is associated with a 26% reduced risk of progression to advanced AMD.
Treatment Options for AMD
Treatment approaches for AMD depend on the type (dry or wet) and stage of the disease. While there is currently no cure for AMD, several treatments can slow progression and help preserve vision.
Treatment for Dry AMD
Currently, there is no FDA-approved treatment to reverse dry AMD. Management focuses on monitoring and slowing progression:
Current Approaches:
- AREDS2 Supplements: For intermediate or advanced dry AMD in one eye, these supplements can reduce the risk of progression by about 25%.
- Regular Monitoring: Frequent eye examinations and self-monitoring with an Amsler grid to detect changes early.
- Lifestyle Modifications: Smoking cessation, dietary changes, and cardiovascular health management.
- Low Vision Aids: For advanced dry AMD, magnifiers, special lighting, and electronic devices can help maximize remaining vision.
Emerging Treatments:
- Geographic Atrophy Treatments: Pegcetacoplan (Syfovre) and avacincaptad pegol (Izervay) are newly FDA-approved treatments for geographic atrophy, the advanced form of dry AMD.
- Stem Cell Therapy: Clinical trials are investigating the potential of stem cell transplantation to replace damaged retinal cells.
- Gene Therapy: Several approaches are being studied to address genetic factors contributing to AMD.
- Neuroprotective Agents: Drugs that may protect remaining photoreceptors from damage are in development.
Treatment for Wet AMD
Wet AMD requires prompt treatment to prevent severe vision loss. Current treatments focus on stopping abnormal blood vessel growth and leakage:
Anti-VEGF Therapy
Anti-vascular endothelial growth factor (anti-VEGF) medications are the standard of care for wet AMD. These drugs are injected into the eye to block the protein (VEGF) that stimulates abnormal blood vessel growth and leakage.
Medication | Brand Name | Typical Dosing | Notes |
---|---|---|---|
Ranibizumab | Lucentis | Monthly injections initially, then as needed | First FDA-approved anti-VEGF for AMD |
Aflibercept | Eylea | Monthly for 3 months, then every 2 months | May require fewer injections than ranibizumab |
Brolucizumab | Beovu | Monthly for 3 months, then every 8-12 weeks | Newer option with potentially longer duration |
Faricimab | Vabysmo | Monthly for 4 months, then up to 16 weeks | Newest FDA-approved treatment (2022) |
Bevacizumab | Avastin | Monthly typically | Used off-label; more cost-effective |
Other Treatment Options
- Photodynamic Therapy (PDT): A light-activated drug (verteporfin) is injected intravenously and activated by a laser to seal leaking blood vessels. Now used primarily in combination with anti-VEGF therapy for specific cases.
- Laser Photocoagulation: Rarely used now but may be appropriate for wet AMD lesions outside the center of the macula.
- Port Delivery System (Susvimo): A surgically implanted reservoir that slowly releases ranibizumab, reducing the need for frequent injections to approximately twice per year.
What to Expect with Treatment
- Anti-VEGF injections are performed in the office under local anesthesia
- The procedure takes only a few minutes
- Most patients report only mild discomfort
- Common side effects include eye redness, floaters, and increased eye pressure
- Serious complications are rare but include infection, retinal detachment, and cataract
- Regular follow-up visits are essential to monitor response and adjust treatment
Early treatment is critical for wet AMD. Studies show that starting anti-VEGF therapy within 7 days of symptom onset leads to significantly better visual outcomes compared to delayed treatment.
Recommended Eye Health Supplements for AMD
For individuals with intermediate or advanced AMD, the National Eye Institute recommends considering AREDS2 formula supplements. Here are some high-quality options based on the research-backed formula:

PreserVision AREDS 2 Formula
The original clinically-tested formula that follows the exact AREDS2 study specifications.
View on Amazon
ICaps AREDS 2 Formula
A popular alternative that follows the AREDS2 formula with slightly different inactive ingredients.
View on Amazon
VitEyes AREDS 2 Plus
An enhanced formula that includes the AREDS2 ingredients plus additional eye-supporting nutrients.
View on AmazonImportant Considerations About Supplements
- Not for everyone: AREDS2 supplements are specifically recommended for people with intermediate AMD or advanced AMD in one eye. They are not recommended for prevention in people without AMD or with early AMD.
- Consult your doctor: Always talk to your eye care professional before starting any supplement regimen, especially if you have other health conditions or take medications.
- Smokers should avoid beta-carotene: Choose a formulation without beta-carotene if you are a current or former smoker, as it may increase lung cancer risk. The formulas listed above do not contain beta-carotene.
- Not a replacement for medical care: Supplements should be used as part of a comprehensive eye care plan that includes regular professional examinations and appropriate medical treatments.
Note: The specific products mentioned above are based on their adherence to the AREDS2 formula and positive user reviews. We may earn a small commission from purchases made through the links at no additional cost to you.
Living with AMD: Adaptive Strategies
For those with advanced AMD and significant vision loss, various strategies and assistive technologies can help maintain independence and quality of life:
Daily Living Adaptations
- High-contrast, large-print materials: Books, newspapers, and playing cards with larger print and better contrast.
- Lighting adjustments: Bright, directed lighting that doesn't produce glare can significantly improve visibility.
- Organizational systems: Consistent placement of items and color-coding can help with identification.
- Talking devices: Watches, calculators, and other devices that provide audio feedback.
- Signature guides: Simple tools to help with signing documents and checks.
Assistive Technology
- Magnification devices: Hand-held or stand magnifiers, magnifying reading glasses, and electronic magnifiers.
- Screen readers and text-to-speech software: Programs that read on-screen text aloud.
- Voice recognition software: Allows computer and smartphone control through voice commands.
- Electronic reading devices: E-readers that allow font size adjustment and contrast enhancement.
- Smartphone accessibility features: Most modern smartphones have built-in magnification, contrast enhancement, and voice assistants.
Support and Resources for AMD Patients
Organizations and Support Groups
Services and Programs
- Low vision rehabilitation services
- Occupational therapy focused on visual impairment
- State vision rehabilitation services
- Library services for the visually impaired
- Support groups (online and in-person)
- Clinical trials (for those interested in research participation)
Conclusion: A Proactive Approach to AMD
Age-related macular degeneration presents significant challenges, but with early detection, appropriate treatment, and lifestyle modifications, many people can maintain good vision and quality of life for years after diagnosis.
The key takeaways from this comprehensive guide include:
- Early detection is critical. Regular eye examinations after age 50 and prompt attention to any changes in vision can lead to earlier diagnosis and better outcomes.
- Know your risk factors. Understanding your personal risk can help you and your eye care professional develop an appropriate monitoring and prevention strategy.
- Lifestyle matters. Smoking cessation, nutritional choices, and cardiovascular health all play significant roles in AMD risk and progression.
- Treatment options continue to improve. For wet AMD, anti-VEGF treatments have revolutionized outcomes. For advanced dry AMD, new treatments are now available, with more in development.
- Adaptation is possible. For those with vision loss from AMD, numerous strategies and technologies can help maintain independence and quality of life.
By taking a proactive approach to eye health and staying informed about the latest developments in AMD prevention and treatment, you can maximize your chances of preserving your vision and maintaining your quality of life as you age.
Medical Disclaimer
This article is intended for informational purposes only and should not be considered medical advice. Always consult with a qualified healthcare provider for diagnosis and treatment of any medical condition, including age-related macular degeneration. The information provided here is based on current research and clinical guidelines as of 2025 but may change as new evidence emerges.
Related Articles
Lutein and Zeaxanthin: Natural Protection for Your Eyes
Learn how these powerful carotenoids can support long-term eye health.
Understanding Dry Eye Syndrome: Causes and Treatments
Explore the causes, symptoms, and effective treatment options for dry eye.
Blue Light and Eye Health: Separating Fact from Fiction
What does the science really say about blue light exposure and eye health?